Skip to main content
. 2020 Sep 17;22(5):4151–4162. doi: 10.3892/mmr.2020.11521

Table III.

Myocardial content of genes in CON (n=8), DOX (n=12) and DOX+Val (n=12) groups.

Protein, ng/ml CON (mean ± SD) DOX (mean ± SD) DOX+Val (mean ± SD)
Renin 27.27±2.32 41.82±3.76a 34.02±3.14a,b
ALD 246.55±68.03 376.87±85.34a 264.25±71.05b
MDA 2.55±0.72 3.99±0.93a 2.72±0.77b
SOD 144.61±32.15 105.48±22.65a 138.84±18.16b
ROS 275.42±71.86 355.64±100.17a 327.41±69.88b
TNF-α 173.52±20.88 260.24±23.47a 211.77±20.59b
IL-6 77.09±17.26 88.28±21.73a 73.27±15.15b
BNP 208.31±33.62 331.77±22.45a 275.73±26.21a,b
NOX1 59.77±8.94 68.87±10.16a 59.13±7.65b
NOX2 44.22±9.55 51.41±7.31a 49.21±3.80b
NOX4 21.76±5.76 27.37±6.41a 21.08±5.49b
a

P<0.05 vs. CON group

b

P<0.05 vs. DOX group. CON, control; DOX, doxorubicin; Val, valsartan; NOX, NAD(P)H oxidase; SOD, superoxide dismutase; ROS, reactive oxygen species; BNP, brain natriuretic peptide; ALD, aldosterone; MDA, malondialdehyde.